<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00761059</url>
  </required_header>
  <id_info>
    <org_study_id>Uni-Koeln-905</org_study_id>
    <nct_id>NCT00761059</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Oral Glucose in Preterm Neonates During Suctioning</brief_title>
  <acronym>Glucose FG</acronym>
  <official_title>Prospective, Placebo-Controlled Blinded Clinical Trial to Study the Efficacy of Orally Administered Glucose 20% for Relieving Pain During Nasopharyngeal Suctioning in Preterm Infants &gt; 1500g Under CPAP-Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nasopharyngeal suctioning is a painful procedure that often becomes necessary in the care of
      preterm infants under CPAP therapy several times a day. Since the use of analgetic and
      sedative drugs is accompanied with multiple side effects these are usually being avoided.
      Glucose 20% has been shown to have an analgesic effect when administered to preterm infants
      previous to some painful procedures (i.e blood sampling).

      In this clinical trial the efficacy of orally administered Glucose 20% for relieving the
      procedural pain of nasopharyngeal suctioning is tested. The investigators' study has a
      cross-over design and is to include 40 patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The PIPP-Score, a validated pain-score, is used to measure the patient's pain</measure>
    <time_frame>during nasopharyngeal suctioning</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Glucose 20%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucose 20%</intervention_name>
    <description>The oral application of 0,3 ml/kg Glucose 20% 3 minutes before nasopharyngeal suctioning</description>
    <arm_group_label>Glucose 20%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aqua</intervention_name>
    <description>The oral application of 0,3 ml/kg Aqua 3 minutes before nasopharyngeal suctioning</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm newborns (&gt;1500g birth weight) up to a gestational age of 36+6 weeks

          -  CPAP respiratory therapy

          -  Parents' given written consent

        Exclusion Criteria:

          -  Diseases complicating neuromuscular evaluation.

          -  Drug abuse by the mother

          -  Administration of other analgetic or sedative drugs within the previous 48h.

          -  Participation in another interventional clinical trial within 4 weeks before the
             beginning of this trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Huenseler, Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology, Children's Hospital, University of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Huenseler, Dr</last_name>
    <phone>0049-221-478-7190</phone>
    <email>christoph.huenseler@uni-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katharina Vezyroglou</last_name>
    <phone>0049-221-478-7190</phone>
    <email>katharina.vezyroglou@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neonatology, Children's Hospital, University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50672</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Huenseler, Dr med</last_name>
      <phone>0049-221-478-7190</phone>
      <email>christoph.huenseler@uni-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Katharina Vezyroglou</last_name>
      <phone>0049-221-478-7190</phone>
      <email>katharina.vezyroglou@uk-koeln.de</email>
    </contact_backup>
    <investigator>
      <last_name>Katharina Vezyroglou</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Kribs, Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernhard Roth, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars Welzing, Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Eifinger, Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne Vierzig, Dr med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2008</study_first_submitted>
  <study_first_submitted_qc>September 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2008</study_first_posted>
  <last_update_submitted>February 24, 2009</last_update_submitted>
  <last_update_submitted_qc>February 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. med Christoph Huenseler</name_title>
    <organization>University of Cologne</organization>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>infant, premature</keyword>
  <keyword>glucose</keyword>
  <keyword>nasopharyngeal suctioning</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

